Investigators are still trying to determine whether the Johnson & Johnson COVID vaccine is linked to a handful of severe blood clotting cases. Natalie Brand reports. (4/14/21)
MICHELLE GRIEGO: As for vaccines, investigators are still trying to determine whether the Johnson & Johnson shot is linked to a handful of blood clotting cases. Natalie Brand has more details from the White House.
NATALIE BRAND: The CDC'S advisory committee is holding an emergency hearing on the Johnson & Johnson vaccine, now paused for use after blood clots were discovered in at least six people.
ROCHELLE WALENSKY: They will analyze the clinical information around these six events post vaccination and others that are reported, and once able to review the best available evidence, deliberate on potential updates to the vaccine recommendations and uses of the vaccine.
NATALIE BRAND: All 50 states have agreed to follow the CDC'S recommendation. But in a private call with the White House, some state leaders voiced concerns the decision could increase vaccine hesitancy.
CHRIS SUNUNU: The ability for governors to re-instill confidence after something like this is 100 times harder than putting the pause on in the first place.
NATALIE BRAND: Surgeon General Vivek Murthy defended the decision on "CBS This Morning."
VIVEK MURTHY: To have a chance to do the actual investigation, to see if there's a real link, and the second decision-- to have that time to communicate with health care professionals about what to look for, but also how to treat these conditions.
NATALIE BRAND: The CDC Advisory Committee is scheduled to vote on updated recommendations for use later this afternoon.
JEFFERY ZIENTS: We believe that by empowering Americans with data and facts, we will strengthen the public's trust in government and increase their confidence in the vaccines.
NATALIE BRAND: Doctors say people who have received the J&J vaccine in the last three weeks need to be on the lookout for symptoms. Those include severe headaches, difficulty moving, shortness of breath, and pain in the legs or abdomen. Natalie Brand, CBS News, the White House.
MICHELLE GRIEGO: Pfizer announced it will boost production of its vaccine by 10% by the end of May to cover the loss of the Johnson & Johnson doses.